170 related articles for article (PubMed ID: 11159536)
1. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).
Kuno Y; Abe A; Emi N; Iida M; Yokozawa T; Towatari M; Tanimoto M; Saito H
Blood; 2001 Feb; 97(4):1050-5. PubMed ID: 11159536
[TBL] [Abstract][Full Text] [Related]
2. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
[TBL] [Abstract][Full Text] [Related]
3. ARG tyrosine kinase activity is inhibited by STI571.
Okuda K; Weisberg E; Gilliland DG; Griffin JD
Blood; 2001 Apr; 97(8):2440-8. PubMed ID: 11290609
[TBL] [Abstract][Full Text] [Related]
4. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.
Peeters P; Raynaud SD; Cools J; Wlodarska I; Grosgeorge J; Philip P; Monpoux F; Van Rompaey L; Baens M; Van den Berghe H; Marynen P
Blood; 1997 Oct; 90(7):2535-40. PubMed ID: 9326218
[TBL] [Abstract][Full Text] [Related]
5. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway.
Nguyen MH; Ho JM; Beattie BK; Barber DL
J Biol Chem; 2001 Aug; 276(35):32704-13. PubMed ID: 11435425
[TBL] [Abstract][Full Text] [Related]
6. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
[TBL] [Abstract][Full Text] [Related]
7. Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk.
Bach MP; Hug E; Werner M; Holch J; Sprissler C; Pechloff K; Zirlik K; Zeiser R; Dierks C; Ruland J; Jumaa H
J Immunol; 2014 Feb; 192(3):1024-33. PubMed ID: 24376268
[TBL] [Abstract][Full Text] [Related]
8. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG
Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809
[TBL] [Abstract][Full Text] [Related]
9. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.
Bai RY; Ouyang T; Miething C; Morris SW; Peschel C; Duyster J
Blood; 2000 Dec; 96(13):4319-27. PubMed ID: 11110708
[TBL] [Abstract][Full Text] [Related]
10. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
Zhong L; Wu CH; Lee WH; Liu CP
J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
[TBL] [Abstract][Full Text] [Related]
11. Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice.
Sprissler C; Belenki D; Maurer H; Aumann K; Pfeifer D; Klein C; Müller TA; Kissel S; Hülsdünker J; Alexandrovski J; Brummer T; Jumaa H; Duyster J; Dierks C
Blood Cancer J; 2014 Aug; 4(8):e240. PubMed ID: 25148222
[TBL] [Abstract][Full Text] [Related]
12. Induction of phagocytosis by a protein tyrosine kinase.
Indik ZK; Park JG; Pan XQ; Schreiber AD
Blood; 1995 Mar; 85(5):1175-80. PubMed ID: 7858249
[TBL] [Abstract][Full Text] [Related]
13. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling.
Ho JM; Beattie BK; Squire JA; Frank DA; Barber DL
Blood; 1999 Jun; 93(12):4354-64. PubMed ID: 10361134
[TBL] [Abstract][Full Text] [Related]
14. An atypical myelodysplastic syndrome with t(9;12)(q22;p12) and TEL gene rearrangement.
Kuno Y; Abe A; Emi N; Iida M; Yamamori T; Tanimoto M; Saito H
Br J Haematol; 1999 Aug; 106(2):570-1. PubMed ID: 10460625
[No Abstract] [Full Text] [Related]
15. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
[TBL] [Abstract][Full Text] [Related]
16. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
Guasch G; Mack GJ; Popovici C; Dastugue N; Birnbaum D; Rattner JB; Pébusque MJ
Blood; 2000 Mar; 95(5):1788-96. PubMed ID: 10688839
[TBL] [Abstract][Full Text] [Related]
17. The IL-15R alpha chain signals through association with Syk in human B cells.
Bulanova E; Budagian V; Pohl T; Krause H; Dürkop H; Paus R; Bulfone-Paus S
J Immunol; 2001 Dec; 167(11):6292-302. PubMed ID: 11714793
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex.
Law CL; Sidorenko SP; Chandran KA; Draves KE; Chan AC; Weiss A; Edelhoff S; Disteche CM; Clark EA
J Biol Chem; 1994 Apr; 269(16):12310-9. PubMed ID: 8163536
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol-3-kinase-dependent phosphorylation of SLP-76 by the lymphoma-associated ITK-SYK fusion-protein.
Hussain A; Faryal R; Nore BF; Mohamed AJ; Smith CI
Biochem Biophys Res Commun; 2009 Dec; 390(3):892-6. PubMed ID: 19850008
[TBL] [Abstract][Full Text] [Related]
20. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.
Pechloff K; Holch J; Ferch U; Schweneker M; Brunner K; Kremer M; Sparwasser T; Quintanilla-Martinez L; Zimber-Strobl U; Streubel B; Gewies A; Peschel C; Ruland J
J Exp Med; 2010 May; 207(5):1031-44. PubMed ID: 20439541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
